Pathway-wide association study implicates multiple sterol transport and metabolism genes in HDL cholesterol regulation

Frontiers in Genetics

Volumn 2, Issue JULY, 2011, Pages

  Wang, Kai ^a,b   Edmondson, Andrew C ^c,d   Li, Mingyao ^c   Gao, Fan ^b   Qasim, Atif N ^c   Devaney, Joseph M ^e   Burnett, Mary Susan ^e   Waterworth, Dawn M ^f   Mooser, Vincent ^f   Grant, Struan F A ^a,c   Epstein, Stephen E ^e   Reilly, Muredach P ^c   Hakonarson, Hakon ^a,c   Rader, Daniel J ^c,d  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WASHINGTON HOSPITAL CENTER   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Cholesterol; Genetic association; GWAS; HDL C; Lipid; Pathway analysis; Sterol metabolism; Sterol transport

Indexed keywords

MUS;

EID: 84875366403     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2011.00041     Document Type: Article

References (74)

1. Abifadel, M., Varret, M., Rabes, J. P., Allard, D., Ouguerram, K., Devillers, M., Cruaud, C, Benjannet, S., Wickham, L, Erlich, D., Derre, A., Villeger, L., Farmer, M., Beucler, I., Bruckert, E., Chambaz, J., Charm, B., Lecerf, J. M., Luc, G., Moulin, P., Weissenbach, J., Prat, A., Krempf, M., Junien, C, Seidah, N. G., and Boileau, C. (2003). Mutations in PCSK9 cause autosomal dominant hyper-cholesterolemia. Nat. Genet. 34, 154-156.
2. Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., Harris, M. A., Hill, D. P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J. C, Richardson, J. E., Ringwald, M., Rubin, G. M., and Sherlock, G. (2000). Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25-29.
3. Askland, K., Read, C, and Moore, J. (2009). Pathways-based analyses of whole-genome association study data in bipolar disorder reveal genes mediating ion channel activity and synaptic neurotransmission. Hum. Genet. 125, 63-79.
4. Aulchenko, Y. S., Ripatti, S., Lindqvist, I., Boomsma, D., Heid, I. M., Pramstaller, P. P., Penninx, B. W., Janssens, A. C, Wilson, J. E, Spector, T., Martin, N. G., Pedersen, N. L., Kyvik, K. O., Kaprio, J., Hofman, A., Freimer, N. B., Jarvelin, M. R., Gyllensten, U., Campbell, H., Rudan, L, Johansson, A., Marroni, E, Hayward, C, Vitart, V., Jonasson, I., Pattaro, C, Wright, A., Hastie, N., Pichler, I., Hicks, A. A., Falchi, M., Willemsen, G., Hottenga, J. J., de Geus, E. J., Montgomery, G. W, Whitfield, J., Magnusson, P., Saharinen, J., Perola, M., Silander, K., Isaacs, A., Sijbrands, E. J., Uitterlinden,A. G.,Witteman, J. C, Oostra, B. A., Elliott, P., Ruokonen, A., Sabatti, C, Gieger, C, Meitinger, T., Kronenberg, E, Doring, A., Wichmann, H. E., Smit, J. H., McCarthy, M. I., van Duijn, C. M., Peltonen, L., and ENGAGE Consortium. (2009). Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41, 47-55.
5. Baranzini, S. E., Galwey, N. W, Wang, J., Khankhanian, P., Lindberg, R., Pelletier, D., Wu, W., Uitdehaag, B. M., Kappos, L., GeneMSA Consortium, Polman, C. H., Matthews, P. M., Hauser, S. L., Gibson, R. A., Oksenberg, J. R., and Barnes, M. R. (2009). Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum. Mol. Genet. 18,2078-2090.
6. Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J., Kwiterovich, P., Shan, B., Barnes, R., and Hobbs, H. H. (2000). Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters. Science 290,1771-1775.
7. Bodzioch, M., Orso, E., Klucken, J., Langmann, T., Bottcher, A., Diederich, W, Drobnik, W., Barlage, S., Biichler, C, Porsch-Ozcurtimez, M., Kaminski, W. E., Hahmann, H. W., Oette, K., Rothe, G., Aslanidis, C, Lackner, K. J., and Schmitz, G. (1999). The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22, 347-351.
8. Breckenridge, W. C, Little, J. A., Alaupovic, P., Wang, C. S., Kuksis, A., Kakis, G., Lindgren, F., and Gardiner, G. (1982). Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 45,161-179.
9. Breckenridge, W C, Little, J. A., Steiner, G., Chow, A., and Poapst, M. (1978). Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N. Engl J. Med. 298, 1265-1273.
10. Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L. H., Roomp, K., van Dam, M., Yu, L., Brewer, C, Collins, J. A., Molhuizen, H. O., Loubser, O., Ouelette, B. E, Fichter, K., Ashbourne-Excoffon, K. J., Sensen, C. W, Scherer, S., Mott, S., Denis, M., Martindale, D., Frohlich, J., Morgan, K., Koop, B., Pimstone, S., Kastelein, J. J., Genest, J. Jr., and Hayden, M. R. (1999). Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22, 336-345.
11. Brown, M. L., Inazu, A., Hesler, C. B., Agellon, L. B., Mann, C, Whitlock, M. E., Marcel, Y. L., Milne, R. W., Koizumi, J., Mabuchi, H., Takeda R., and Tall, A. R. (1989). Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature 342,448-451.
12. Canovasa, E., Quintanillab, R., Badaouia, B., Porredona, C, Gallardoa, D., Pena, R. N., Diaz, I., and Amills, M. (2009). Pig HDL-binding protein (HDLBP) genotype is associated with intramuscular fat percentage.Livest. Sci. 126,298-301.
13. Chen, S. N., Cilingiroglu, M., Todd, J., Lombardi, R., Willerson, J. T., Gotto, A. M. Jr., Ballantyne, C. M., and Marian, A. J. (2009). Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis. BMC Med. Genet. 10, 111. doi: 10.1186/1471-2350-10-111
14. Cohen, J. C, Boerwinkle, E., Mosley, T. H. Jr., and Hobbs, H. H. (2006). Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl. J. Med. 354,1264-1272.
15. Couture, P., Otvos, J. D., Cupples, L. A., Wilson, P. W., Schaefer, E. J., and Ordovas, J. M. (1999). Association of the A-204C polymorphism in the cholesterol 7alpha-hydroxylase gene with variations in plasma low density lipoprotein cholesterol levels in the Framingham Offspring Study. J. Lipid Res. 40, 1883-1889.
16. Dinu, V., Miller, P. L, and Zhao, H. (2007). Evidence for association between multiple complement pathway genes and AMD. Genet. Epidemiol. 31,224-237.
17. Edmondson, A. C, and Rader, D. J. (2008). Genome-wide approaches to finding novel genes for lipid traits: the start of a long road. Circ. Cardio-vasc. Genet. 1, 3-6.
18. Garcia, C. K., Wilund, K., Area, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, E, Grishin, N., Barnes, R., Cohen, J. C, and Hobbs, H. H. (2001). Autosomal recessive hyper-cholesterolemia caused by mutations in a putative LDL receptor adaptor protein. Science 292, 1394-1398.
19. Goldstein, D. B. (2009). Common genetic variation and human traits. N. Engl.J. Med. 360, 1696-1698.
20. Haemmerle, G., Zimmermann, R., Strauss, J. G., Kratky, D., Riederer, M., Knipping, G., and Zechner, R. (2002). Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle. J. Biol. Chetn. 277, 12946-12952.
21. Helgadottir, A., Manolescu, A., Helgason, A., Thorleifsson, G., Thorsteinsdottir, U., Gudbjartsson, D. E, Gretarsdottir, S., Magnusson, K. P., Gudmundsson, G., Hicks, A., Jonsson, T., Grant, S. E, Sainz, J., O'Brien, S. J., Sveinbjornsdottir, S., Valdimarsson, E. M., Matthiasson, S. E., Levey, A. I., Abramson, J. L, Reilly, M. P., Vaccarino, V., Wolfe, M. L., Gudnason, V., Quyyumi, A. A., Topol, E. J., Rader, D. J., Thorgeirsson, G., Gulcher, J. R., Hakonarson, H., Kong, A., and Stefansson, K. (2006). A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity specific risk of myocardial infarction. Nat. Genet. 38, 68-74.
22. Hobbs, H. H., Brown, M. S., Goldstein, J. L., and Russell, D. W. (1986). Deletion of exon encoding cysteine-rich repeat of low density lipoprotein receptor alters its binding specificity in a subject with familial hyperc-holesterolemia. J. Biol. Chem. 261, 13114-13120.
23. Hollander, M., and Wolfe, D. A. (1999). Non-parametric Statistical Methods. New York: Wiley.
24. Holleboom,A. G.,Vergeer,M.,Hovingh, G. K., Kastelein, J. J., and Kuivenhoven, J. A. (2008). The value of HDL genetics. Curr. Opin. Lipidol. 19, 385-394.
25. Holmans, P., Green, E. K., Pahwa, J. S., Ferreira, M. A., Purcell, S. M., Sklar, P., Wellcome Trust Case-Control Consortium, Owen, M. J., O'Donovan, M. C, and Craddock, N. (2009). Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. Am. J. Hum. Genet. 85, 13-24.
26. Homanics, G. E., Smith, T. J., Zhang, S. H., Lee, D., Young, S. G., and Maeda, N. (1993). Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc. Natl.Acad. Sci. U.S.A. 90, 2389-2393.
27. Huang, L. S., Voyiaziakis, E., Markenson, D. E, Sokol, K. A., Hayek, T., and Breslow, J. L. (1995). apo B gene knockout in mice results in embryonic lethality in homozygotes and neural tube defects, male infertility, and reduced HDL cholesterol ester and apo A-I transport rates in heterozygotes. J. Clin. Invest. 96, 2152-2161.
28. Inazu, A., Brown, M. L., Hesler, C. B., Agellon, L. B., Koizumi, J., Takata, K., Maruhama, Y, Mabuchi, H., and Tall, A. R. (1990). Increased high-density lipoprotein levels caused by a common cholesterylester transfer protein gene mutation. N Engl. J. Med. 323,1234-1238.
29. Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., and Herz, J. (1993). Hypercho-lesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92, 883-893.
30. Jones, C, Hammer, R. E., Li, W. P., Cohen, J. C, Hobbs, H. H., and Herz, J. (2003). Normal sorting but defective endocytosis of the low density lipoprotein receptor in mice with autosomal recessive hyperc-holesterolemia. J. Biol. Chem. 278, 29024-29030.
31. Jones, L., Holmans, P. A., Hamshere, M. L., Harold, D., Moskvina, V., Ivanov, D., Pocklington, A., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Pahwa, J. S., Jones, N., Stretton, A., Morgan, A. R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M. K., Brayne, C, Rubinsztein, D. C, Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K. S., Passmore, P. A., Craig, D., McGuinness, B., Todd, S., Holmes, C, Mann, D., Smith, A. D., Love, S., Kehoe, P. G., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, E, Schurmann, B., Heun, R., Kolsch, H., van den, Bussche, H., Heuser, I., Peters, O., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L, Hampel, H., Hull, M., Rujescu, D., Goate, A. M., Kauwe, J. S., Cruchaga, C, Nowotny, P., Morris, J. C, Mayo, K., Livingston, G., Bass, N. J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C. E., Singleton, A. B., Guerreiro, R., Miihleisen, T. W., Nothen, M. M., Moebus, S., Jockel, K. H., Klopp, N., Wichmann, H. E., Riither, E., Carrasquillo, M. M., Pankratz, V. S., Younkin, S. G., Hardy, J., O'Donovan, MC, Owen, M. J., Williams, J. (2010). Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. PLoS ONE 5, el3950. doi: 10.1371/journal.pone.0013950
32. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., and Hirakawa, M. (2010). KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360.
33. Kathiresan, S., Wilier, C. J., Peloso, G. M., Demissie, S., Musunuru, K., Schadt, E. E., Kaplan, L., Bennett, D., Li, Y, Tanaka, T., Voight, B. F., Bonnycastle, L. L., Jackson, A. U., Crawford, G., Surti, A., Guiducci, C, Burtt, N. P., Parish, S., Clarke, R., Zelenika, D., Kubalanza, K. A., Morken, M. A., Scott, L. J., Stringham, H. M., Galan, P., Swift, A. J., Kuusisto, J., Bergman, R. N., Sundvall, J., Laakso, M., Ferrucci, L., Scheet, P., Sanna, S., Uda, M., Yang, Q., Lunetta, K. L., Dupuis, J., de Bakker, P. I., O'Donnell, C. J., Chambers, J. C, Kooner, J. S., Hercberg, S., Meneton, P., Lakatta, E. G., Scuteri, A., Schlessinger, D., Tuomilehto, J., Collins, E S., Groop, L., Altshuler, D., Collins, R., Lathrop, G. M., Melander, O., Salomaa, V., Peltonen, L., OrhoMelander, M., Ordovas, J. M., Boehnke, M., Abecasis, G. R., Mohlke, K. L, and Cupples, L. A. (2009). Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65.
34. Klett, E. L., Lu, K., Kosters, A., Vink, E., Lee, M. H., Altenburg, M., Shefer, S., Batta, A. K., Yu, H., Chen, J., Klein, R., Looije, N., Oude-Elferink, R., Groen, A. K., Maeda, N., Salen, G., and Patel, S. B. (2004). A mouse model of sitosterolemia: absence of Abcg8/sterolin-2 results in failure to secrete biliary cholesterol. BMC Med. 2, 5. doi: 10.1186/1741-7015-2-5
35. Koishi, R., Ando, Y, Ono, M., Shimamura, M., Yasumo, H., Fujiwara, T., Horikoshi, H., and Furukawa, H. (2002). Angptl3 regulates lipid metabolism in mice. Nat. Genet. 30, 151-157.
36. Koizumi, J., Mabuchi, H., Yoshimura, A., Michishita, I., Takeda, M., Itoh, H., Sakai, Y, Sakai, T., Ueda, K., and Takeda, R. (1985). Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. Atherosclerosis 58, 175-186.
37. Krakowiak, P. A., Wassif, C. A., Kratz, L., Cozma, D., Kovarova, M., Harris, G., Grinberg, A., Yang, Y, Hunter, A. G., Tsokos, M., Kelley, R. I., and Porter, E D. (2003). Lathosterolosis: an inborn error of human and murine cholesterol synthesis due to lathosterol 5-desaturase deficiency. Hum. Mol. Genet. 12, 1631-1641.
38. Kurasawa, T., Yokoyama, S., Miyake, Y, Yamamura, T., and Yamamoto, A. (1985). Rate of cholesteryl ester transfer between high and low density lipoproteins in human serum and a case with decreased transfer rate in association with hyperal-phalipoproteinemia. J. Biochem. 98, 1499-1508.
39. Lesnick, T. G., Papapetropoulos, S., Mash, D. C, Ffrench-Mullen, J., Shehadeh, L., de Andrade, M., Henley, J. R., Rocca, W A., Ahlskog, J. E., and Maraganore, D. M. (2007). A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 3, e98. doi: 10.1371/journal.pgen. 0030098
40. Li-Hawkins, J., Lund, E. G., Turley, S. D., and Russell, D. W. (2000). Disruption of the oxysterol 7alpha-hydroxylase gene in mice. J. Biol. Chem. 275,16536-16542.
41. Maher, B. (2008). Personal genomes: the case of the missing heritability. Nature 456, 18-21.
42. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., McCarthy, M. I., Ramos, E. M., Cardon, L. R., Chakravarti, A., Cho, J. H., Guttmacher, A. E., Kong, A., Kruglyak, L., Mardis, E., Rotimi, C. N., Slatkin, M., Valle, D., Whittemore, A. S., Boehnke, M., Clark, A. G., Eichler, E. E., Gibson, G., Haines, J. L., Mackay, T. F., McCarroll,S.A.,andVisscher,P. M. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753.
43. Miettinen, H. E., Rayburn, H., and Krieger, M. (2001). Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor (SR-BI)-deficient mice. J. Clin. Invest. 108, 1717-1722.
44. Myocardial Infarction Genetics Consortium, Kathiresan, S., Voight, B. R, Purcell, S., Musunuru, K., Ardissino, D., Mannucci, P. M., Anand, S., Engert, J. C, Samani, N. J., Schunkert, H., Erdmann, J., Reilly, M. P., Rader, D. J., Morgan, T., Spertus, J. A., Stoll, M., Girelli, D., McKeown, PP, Patterson, C. C, Siscovick, D. S., O'Donnell, CJ, Elosua, R., Peltonen, L., Salomaa, V., Schwartz, S. M., Melander, O., Altshuler, D., Ardissino, D., Merlini, P. A., Berzuini, C, Bernardinelli, L., Peyvandi, E, Tubaro, M., Celli, P., Ferrario, M., Fetiveau, R., Marziliano, N., Casari, G., Galli, M., Ribichini, E, Rossi, M., Bernardi, E, Zonzin, P., Piazza, A., Mannucci, P. M., Schwartz, S. M., Siscovick, D. S., Yee, J., Friedlander, Y., Elosua, R., Marrugat, J., Lucas, G., Subirana, I., Sala, J., Ramos, R., Kathiresan, S., Meigs, J. B., Williams, G., Nathan, D. M., MacRae, CA, O'Donnell, CJ, Salomaa, V., Havulinna, A. S., Peltonen, L., Melander, O., Berglund, G., Voight, B. E, Kathiresan, S., Hirschhorn, J. N., Asselta, R., Duga, S., Spreafico, M., Musunuru, K., Daly, M. J., Purcell, S., Voight, B. E, Purcell, S., Nemesh, J., Korn, J. M., McCarroll, S. A., Schwartz, S. M., Yee, J., Kathiresan, S., Lucas, G., Subirana, L, Elosua, R., Surti, A., Guiducci, C, Gianniny, L., Mirel, D., Parkin, M., Burtt, N., Gabriel, S. B., Samani, N. J., Thompson, J. R., Braund, P. S., Wright, B. J., Balmforth, A. J., Ball, S. G., Hall, A. S., Wellcome Trust, Case Control Consortium, Schunkert, H., Erd mann, J., Linsel-Nitschke, P., Lieb, W, Ziegler, A., Konig, I., Heng-stenberg, C, Fischer, M., Stark, K., Grosshennig, A., Preuss, M., Wichmann, H. E., Schreiber, S., Schunkert, H., Samani, N. J., Erdmann, J., Ouwehand, W., Hengstenberg, C, Deloukas, P., Scholz, M., Cambien, E, Reilly, M. P., Li, M., Chen, Z., Wilensky, R., Matthai, W., Qasim, A., Hakonarson, H. H., Devaney, J., Burnett, M. S., Pichard, A. D., Kent, K. M., Satler, L., Lindsay, J. M., Waksman, R., Knouff, C. W., Waterworth, D. M., Walker, M. C, Mooser, V, Epstein, S. E., Rader, D. J., Scheffold, T., Berger, K., Stoll, M., Huge, A., Girelli, D., Martinelli, N., Olivieri, O., Corrocher, R., Morgan, T., Spertus, J. A., McKeown, P., Pat terson, C. C, Schunkert, H., Erd mann, E., Linsel-Nitschke, P., Lieb, W, Ziegler, A., Konig, I. R., Heng stenberg, C, Fischer, M., Stark, K., Grosshennig, A., Preuss, M., Wichmann, H. E., Schreiber, S., Holm, H., Thorleifsson, G., Thorsteinsdottir, U., Stefansson, K., Engert, J. C, Do, R., Xie, C, Anand, S., Kathiresan, S., Ardissino, D., Mannucci, P. M., Siscovick, D., O'Donnell, C. J., Samani, N. J., Melander, O., Elosua, R., Peltonen, L., Salomaa, V, Schwartz, S. M., and Altshuler, D. (2009). Genomewide association of earlyonset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334-341.
45. Orso, E., Broccardo, C, Kaminski, W. E., Bottcher, A., Liebisch, G., Drobnik, W, Gotz, A., Chambenoit, O., Diederich,W,Langmann,T., Spruss, T., Luciani, M. F., Rothe, G., Lackner, K. J., Chimini, G., and Schmitz, G. (2000). Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abel-deficient mice. Nat. Genet. 24, 192-196.
46. Pan, W. (2008). Network-based model weighting to detect multiple loci influencing complex diseases. Hum. Genet. 124,225-234.
47. Perry, J. R., McCarthy, M. I., Hattersley, A. T., Zeggini, E., Wellcome Trust Case Control Consortium, Weedon, M. N., and Frayling, T. M. (2009). Interrogating type 2 diabetes genome-wide association data using a biological pathway-based approach. Diabetes 58, 1463-1467.
48. Pullinger, C. R., Eng, C, Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., and Kane, J. P. (2002). Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype./. Clin. Invest. 110, 109-117.
49. Rashid, S., Curtis, D. E., Garuti, R., Anderson, N. N., Bashmakov, Y, Ho, Y K., Hammer, R. E., Moon, Y A., and Horton, J. D. (2005). Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. Proc. Natl. Acad. Sci. U.S.A. 102,5374-5379.
50. Reiner, A., Yekutieli, D., and Benjamini, Y. (2003). Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368-375.
51. Roberts, C. G., Shen, H., Mitchell, B. D., Damcott, C. M., Shuldiner, A. R., and Rodriguez, A. (2007). Variants in scavenger receptor class B type I gene are associated with HDL cholesterol levels in younger women. Hum. Hexed. 64, 107-113.
52. Rust, S., Rosier, M., Funke, H., Real, J., Amoura, Z., Piette, J. C, Deleuze, J. E, Brewer, H. B., Duverger, N., Denefle, P., and Assmann, G. (1999). Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22, 352-355.
53. Sabatti, C, Service, S. K., Hartikainen, A. L., Pouta, A., Ripatti, S., Brodsky, J., Jones, C. G., Zaitlen, N. A., Varilo, T., Kaakinen, M., Sovio, U., Ruokonen, A., Laitinen, J., Jakkula, E., Coin, L., Hoggart, C, Collins, A., Turunen, H., Gabriel, S., Elliot, P., McCarthy, M. I., Daly, M. J., Jarvelin, M. R., Freimer, N. B., and Peltonen, L. (2009). Genomewide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 41,35-46.
54. Shefer, S., Salen, G., Batta, A. K., Honda, A., Tint, G. S., Irons, M., Elias, E. R., Chen, T. C, and Holick, M. E (1995). Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes./. Clin. Invest. 96, 1779-1785.
55. Soutar, A. K., and Naoumova, R. P. (2007). Mechanisms of disease: genetic causes of familial hypercho-lesterolemia. Nat. Clin. Pract. Car-diovascMed. 4, 214-225.
56. Steinthorsdottir, V, Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B., Styrkarsdottir, U., Gretarsdottir, S., Emilsson, V, Ghosh, S., Baker, A., Snorradottir, S., Bjarnason, H., Ng, M. C, Hansen, T., Bagger, Y., Wilensky, R. L, Reilly, M. P., Adeyemo, A., Chen, Y, Zhou, J., Gudnason, V, Chen, G., Huang, H., Lashley, K., Doumatey, A., So, W Y., Ma, R. C, Andersen, G., Borch-Johnsen, K., Jorgensen, T., van Vliet-Ostaptchouk, J. V, Hofker, M. H., Wijmenga, C, Christiansen, C, Rader, D. J., Rotimi, C, Gurney, M., Chan, J. C, Pedersen, O., Sigurdsson, G., Gulcher, J. R., Thorsteinsdottir, U., Kong, A., and Stefansson, K. (2007). A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770-775.
57. Subramanian, A., Tamayo, P., Mootha, V K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., and Mesirov, J. P. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102, 15545-15550.
58. Sun, Y M., Wang, L. E, Li, J., Li, Z. Q., and Pan, W. (2009). The 223A>G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease. Eur. J. Clin. Pharmacol. 65, 157-161.
59. Takada, D., Emi, M., Ezura, Y, Nobe, Y, Kawamura, K., lino, Y,Katayama,Y, Xin, Y, Wu, L. L., Larringa-Shum, S., Stephenson, S. H., Hunt, S. C, and Hopkins, P. N. (2002). Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholes-terolemiakindred./.Hum. Genet.47, 656-664.
60. Teslovich, T. M., Musunuru, K., Smith, A. V, Edmondson, A. C, Stylianou, I. M., Koseki, M., Pirruccello, J. P., Ripatti, S., Chasman, D. I., Wilier, C. J., Johansen, C. T., Fouchier, S. W., Isaacs, A., Peloso. G. M., Barbalic, M., Ricketts, S. L, Bis, J. C, Aulchenko, Y S., Thorleifsson, G., Feitosa, M. E, Chambers, J., Orho-Melander, M., Melander, O., John son, T., Li, X., Guo, X., Li, M., Shin Cho, Y, Jin Go, M., Jin, Kim, Y., Lee, J. Y, Park, T., Kim, K., Sim, X., Twee-Hee, Ong, R., Croteau-Chonka, D. C, Lange, L. A., Smith, J. D., Song, K., Hua Zhao, J., Yuan, X., Luan, J., Lamina, C, Ziegler, A., Zhang, W, Zee, R. Y, Wright, A. E, Witteman, J. C, Wilson, J. E, Willemsen, G., Wichmann, H. E., Whitfield, J. B., Waterworth, D. M., Wareham, N. J., Waeber, G., Vollenweider, P., Voight, B. E, Vitart, V, Uitterlinden, A. G., Uda, M., Tuomilehto, J., Thompson, J. R., Tanaka, T., Surakka, I., Stringham, H. M., Spector, T. D., Soranzo, N., Smit, J. H., Sinisalo, J., Silander, K., Sijbrands, E. J., Scuteri, A., Scott, J., Schlessinger, D., Sanna, S., Salomaa, V, Saharinen, J., Sabatti, C. Ruokonen, A., Rudan, I., Rose, L. M., Roberts, R., Rieder, M., Psaty, B. M., Pramstaller, P. P., Pichler, I., Perola, M., Penninx, B. W, Peder sen, N. L., Pattaro, C, Parker, A. N., Pare, G., Oostra, B. A., O'Donnell, CJ, Nieminen, M. S., Nickerson, D. A., Montgomery, G. W, Meitinger, T., McPherson, R., McCarthy, MI, McArdle, W, Masson, D., Martin, N. G., Marroni, E, Mangino, M., Magnusson, P. K., Lucas, G., Luben, R., Loos, R. J., Lokki, M. L., Lettre, G., Langenberg, C, Launer, L. J., Lakatta, E. G., Laaksonen, R., Kyvik, K. O., Kronenberg, E, Konig, I. R., Khaw, K. T., Kaprio, J., Kaplan, L. M., Johansson, A., Jarvelin, M. R., Janssens, A. C, Ingelsson, E., Igl, W., Kees Hovingh, G., Hottenga, J. J., Hofman, A., Hicks, A. A., Hengstenberg, C, Heid, I. M., Hayward, C, Havulinna, A. S., Hastie, N. D., Harris, T. B., Haritunians, T., Hall, A. S., Gyllensten, U., Guiducci, C, Groop, L. C, Gonzalez, E., Gieger, C, Freimer, N. B., Ferrucci, L., Erdmann, J., Elliott, P., Ejebe, K. G., Doring, A., Dominiczak, A. E, Demissie, S., Deloukas, P., de, Geus, E. J., de, Faire, U., Crawford, G., Collins, F. S., Chen, Y. D., Caulfield, M. J., Campbell, H., Burtt, N. P., Bonnycastle, L. L., Boomsma, D. I., Boekholdt, S. M., Bergman, R. N., Barroso, I., Bandinelli, S., Ballantyne, C. M., Assimes, T. L., Quertermous, T., Altshuler, D., Seielstad, M., Wong, T. Y., Tai, E. S., Feranil, A. B., Kuzawa, C. W., Adair, L. S., Taylor, HA. Jr. Borecki, I. B., Gabriel, S. B., Wilson, J. G., Holm, H., Thorsteinsdottir, U., Gudnason, V., Krauss, R. M., Mohlke, K. L., Ordovas, J. M., Munroe, P. B., Kooner, J. S., Tall, A. R., Hegele, R. A., Kastelein, J. J., Schadt, E. E., Rotter, J. I., Boerwinkle, E., Strachan, D. P., Mooser, V., Stefansson, K., Reilly, M. P., Samani, N. J., Schunkert, H., Cupples, L. A., Sandhu, M. S., Ridker, P. M., Rader, D. J., van, Duijn, C. M., Peltonen, L., Abecasis, G. R., Boehnke, M.,Kathiresan,S. (2010). Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713.
61. Torkamani, A., Topol, E. J., and Schork, N. J. (2008). Pathway analysis of seven common diseases assessed by genome-wide association. Genotnics 92, 265-272.
62. Wang, J., Freeman, D. J., Grundy, S. M., Levine, D. M., Guerra, R., and Cohen, J. C. (1998). Linkage between cholesterol 7alpha-hydroxylase and high plasma low-density lipoprotein cholesterol concentrations./. Clin. Invest. 101, 1283-1291.
63. Wang, K., Li, M., and Bucan, M. (2007). Pathway-based approaches for analysis of genomewide association studies. Am. J. Hum. Genet. 81, 1278-1283.
64. Wang, K., Li, M., and Hakonarson, H. (2010). Analysing biological pathways in genome-wide association studies.NatRev. Genet. 11,843-854.
65. Wang, K., Zhang, H., Kugathasan, S., Annese, V., Bradfield, 1. P., Russell, R. K., Sleiman, P. M., Imielinski, M., Glessner, 1., Hou, C, Wilson, D. C, Walters, T., Kim, C, Frackelton, E. C, Lionetti, P., Barabino, A., Van Limbergen, 1., Guthery, S., Denson, L., Piccoli, D., Li, M., Dubinsky, M., Silverberg, M., Griffiths, A., Grant, S. E, Satsangi, 1., Baldassano, R., and Hakonarson, H. (2009a). Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn Disease. Am. J. Hum. Genet. 84, 399-405.
66. Wang, K., Zhang, H., Ma, D., Bucan, M., Glessner, J. T., Abrahams, B. S., Salyakina, D., Imielinski, M., Bradfield, J. P., Sleiman, P. M., Kim, C. E., Hou, C, Frackelton, E., Chiavacci, R., Takahashi, N., Sakurai, T., Rappaport, E., Lajonchere, C. M., Munson, J., Estes, A., Korvatska, O., Piven, J., Sonnenblick, L. I., Alvarez Retuerto, A. I., Herman, E. I., Dong, H., Hutman, T., Sigman, M., Ozonoff, S., Klin, A., Owley, T., Sweeney, J. A., Brune, C. W., Cantor, R. M., Bernier, R., Gilbert, J. R., Cuccaro, M. L., McMahon, W. M., Miller, J., State, M. W, Wassink, T. H., Coon, H., Levy, S. E., Schultz, R. T., Nurnberger, J. I., Haines, J. L., Sutcliffe, J. S., Cook, E. H., Minshew, N. J., Buxbaum, J. D., Dawson, G., Grant, S. E, Geschwind, D. H., Pericak-Vance, M. A., Schellenberg, G. D., and Hakonarson, H. (2009b). Common genetic variants on 5p 14.1 associate with autism spectrum disorders. Nature 459, 528-533.
67. Wassif, C. A., Zhu, P., Kratz, L, Krakowiak, P. A., Battaile, K. P., Weight, F. F., Grinberg, A., Steiner, R. D., Nwokoro, N. A., Kelley, R. I., Stewart, R. R., and Porter, F. D. (2001). Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH/Smith-Lemli-Opitz syndrome. Hum. Mol. Genet. 10, 555-564.
68. Waterham, H. R., Koster, J., Romeijn, G. J., Hennekam, R. C, Vreken, P., Andersson, H. C, Fitz-Patrick, D. R., Kelley, R. I., and Wanders, R. J. (2001). Mutations in the 3beta-hydroxysterol Delta24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am. J. Hum. Genet. 69, 685-694.
69. Wechsler, A., Brafman, A., Shafir, M., Heverin, M., Gottlieb, H., Damari, G., Gozlan-Kelner, S., Spivak, I., Moshkin, O., Fridman, E., Becker, Y., Skaliter, R., Einat, P., Faerman, A., Bjorkhem, I., and Feinstein, E. (2003). Generation of viable cholesterol-free mice. Science 302, 2087.
70. Wiersma, H., Nijstad, N., de Boer, J. E, Out, R., Hogewerf, W., Van Berkel, T. J., Kuipers, E, and Tietge, U. J. (2009). Lack of Abcgl results in decreased plasma HDL cholesterol levels and increased biliary cholesterol secretion in mice fed a high cholesterol diet. Atherosclerosis 206, 141-147.
71. Willner, E. L, Tow, B., Buhman, K. K., Wilson, M., Sanan, D. A., Rudel, L. L., Farese, R. V. Jr. (2003). Deficiency of acyl CoA: cholesterol acyl-transferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 100,1262-1267.
72. Wolfrum, C, Poy, M. N., and Stoffel, M. (2005). Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. NatMed. 11,418-422.
73. Young, S. G., Bertics, S. J., Curtiss, L. K., Dubois, B. W, and Witztum, J. L. (1987). Genetic analysis of a kindred with familial hypobetalipopro-teinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100. J. Clin. Invest. 79,1842-1851.
74. Zhang, S. H., Reddick, R. L, Piedrahita, J. A., and Maeda, N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468-471.